T. Bisgin Et Al. , "Is splenectomy a prognostic factor for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis (PM)?," The 30th Biennial Congress of ISUCRS 2020 , Ageo, Japan, pp.25, 2020
Bisgin, T. Et Al. 2020. Is splenectomy a prognostic factor for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis (PM)?. The 30th Biennial Congress of ISUCRS 2020 , (Ageo, Japan), 25.
Bisgin, T., Sökmen, S., Canda, A., Avkan Oğuz, V., Barlık Obuz, F., Karaoğlu, A., ... Sagol, Ö.(2020). Is splenectomy a prognostic factor for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis (PM)? . The 30th Biennial Congress of ISUCRS 2020 (pp.25). Ageo, Japan
Bisgin, TAYFUN Et Al. "Is splenectomy a prognostic factor for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis (PM)?," The 30th Biennial Congress of ISUCRS 2020, Ageo, Japan, 2020
Bisgin, TAYFUN Et Al. "Is splenectomy a prognostic factor for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis (PM)?." The 30th Biennial Congress of ISUCRS 2020 , Ageo, Japan, pp.25, 2020
Bisgin, T. Et Al. (2020) . "Is splenectomy a prognostic factor for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis (PM)?." The 30th Biennial Congress of ISUCRS 2020 , Ageo, Japan, p.25.
@conferencepaper{conferencepaper, author={TAYFUN BİŞGİN Et Al. }, title={Is splenectomy a prognostic factor for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis (PM)?}, congress name={The 30th Biennial Congress of ISUCRS 2020}, city={Ageo}, country={Japan}, year={2020}, pages={25} }